DevCurationThe Premier Voice of the Entire Tech Ecosystem
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Latest
5th Line5th Line|North Island VenturesNorth Island Ventures|America's Quantum Industrial Policy: Why Washington's Quantum Strategy Matters for Investors and EnterpriseAmerica's Quantum Industrial Policy: Why Washington's Quantum Strategy Matters for Investors and Enterprise|Kind Designs Raises $10M Pre-Series A for Living SeawallsKind Designs Raises $10M Pre-Series A for Living Seawalls|Alpaca Raises $135M to Expand AI-Native Brokerage InfrastructureAlpaca Raises $135M to Expand AI-Native Brokerage Infrastructure|Lendistry Secures $100M East West Bank Credit Facility for Airport LendingLendistry Secures $100M East West Bank Credit Facility for Airport Lending|DeweyLearn Raises $5M Series A for AI Skills AssessmentDeweyLearn Raises $5M Series A for AI Skills Assessment|Sable Raises $45M Led by Sequoia and 8VC to Scale AI Employee AidanSable Raises $45M Led by Sequoia and 8VC to Scale AI Employee Aidan|Whale Raises $40M Series C3 Extension to Scale Enterprise AI OperationsWhale Raises $40M Series C3 Extension to Scale Enterprise AI Operations|EverSettled Raises $5M Seed Round Led by Emergence Capital to Modernize ProbateEverSettled Raises $5M Seed Round Led by Emergence Capital to Modernize Probate|5th Line5th Line|North Island VenturesNorth Island Ventures|America's Quantum Industrial Policy: Why Washington's Quantum Strategy Matters for Investors and EnterpriseAmerica's Quantum Industrial Policy: Why Washington's Quantum Strategy Matters for Investors and Enterprise|Kind Designs Raises $10M Pre-Series A for Living SeawallsKind Designs Raises $10M Pre-Series A for Living Seawalls|Alpaca Raises $135M to Expand AI-Native Brokerage InfrastructureAlpaca Raises $135M to Expand AI-Native Brokerage Infrastructure|Lendistry Secures $100M East West Bank Credit Facility for Airport LendingLendistry Secures $100M East West Bank Credit Facility for Airport Lending|DeweyLearn Raises $5M Series A for AI Skills AssessmentDeweyLearn Raises $5M Series A for AI Skills Assessment|Sable Raises $45M Led by Sequoia and 8VC to Scale AI Employee AidanSable Raises $45M Led by Sequoia and 8VC to Scale AI Employee Aidan|Whale Raises $40M Series C3 Extension to Scale Enterprise AI OperationsWhale Raises $40M Series C3 Extension to Scale Enterprise AI Operations|EverSettled Raises $5M Seed Round Led by Emergence Capital to Modernize ProbateEverSettled Raises $5M Seed Round Led by Emergence Capital to Modernize Probate
DevCuration

The premier voice of the tech ecosystem, from ideation to enterprise.

Explore

  • Where the Money Moved
  • Events
  • Articles & Analysis

Spotlights

  • Investor Spotlight
  • Company Spotlight
  • Frameworks

Company

  • About Us
  • Privacy Policy
  • Terms of Service
© 2026 DevCuration. All rights reserved.
TwitterLinkedIn
Logos provided by Logo.dev
Back to articles
February 12, 2026
•Jesse LandryJesse Landry

ILiAD Biotechnologies Secures $115M in Series B Funding

Some companies raise capital. Others inhale it like oxygen, hold it in their lungs, and come back speaking in full sentences. ILiAD Biotechnologies just secured $115M in an oversubscribed Series B. RA Capital Management led the round with the kind of conviction that only shows up after deep diligence. Janus Henderson Investors and BNP Paribas Asset Management Alts stepped in as new believers. Existing backers AI Life Sciences and a multinational pharmaceutical company doubled down. That is not polite support. That is capital leaning forward. Congratulations to Keith Rubin, M.D., Founder and CEO, and Stephanie Noviello, M.D., M.P.H., CMO, for navigating a clinical stage biotech through a market that rewards proof, not promises.

Now the science. ILiAD Biotechnologies is advancing BPZE1, a live attenuated intranasal pertussis vaccine built to do what current shots struggle to accomplish. Not just blunt symptoms. Not just boost antibodies on paper. Block colonization. Reduce transmission. Build durable mucosal immunity where infection actually begins. 4 completed clinical trials in healthy adults. A 300-participant Phase 2b human challenge trial demonstrating durable mucosal immunity and reduced nasal colonization. FDA Fast Track designation already in hand. A pivotal human challenge trial planned to begin in 2026 with data expected in 2027. This is not theoretical ambition. This is a program moving on a clock.

The name ILiAD carries a certain poetry. An epic battle. Pertussis has been staging quiet comebacks while legacy vaccines fade in durability. ILiAD Biotechnologies is not polishing yesterday’s solution. The approach is intranasal, live attenuated, engineered to meet the pathogen at the door instead of chasing it down the hallway. Change transmission and you change the math of public health.

The $115M does more than finance Phase 3 development. It strengthens the broader B Tech Vector Platform, a proprietary system using attenuated Bordetella pertussis as a vector to deliver antigens from other pathogens. Tuberculosis is already in scope with support from NIH and NIAID. When a platform moves from whooping cough to TB, you are not building a single asset. You are building leverage with a lab coat.

There is a lesson for founders watching this unfold. Data compounds. Regulatory progress compounds. Discipline compounds. Oversubscribed rounds rarely appear for science projects. They appear for programs that survive scrutiny and keep advancing when sentiment wobbles.

Back to all articles

Related Articles

Where the Money Moved
Senra Systems Raises $65M Series B to Scale Aerospace Wire Harness Manufacturing
Jul 17, 2026
Where the Money Moved
410 Medical Raises $14M Series B Led by Hatteras to Expand LifeFlow
Jul 15, 2026
Where the Money Moved
Sabanto Raises Series B Led by Leaps by Bayer to Expand Autonomous Farm Technology
Jul 15, 2026
Where the Money Moved
Databento Raises $97M Series B Led by NEA to Expand Financial Market Data Platform
Jul 12, 2026
Where the Money Moved
Vendelux Raises $50M Series B for B2B Event Intelligence
Jul 12, 2026

More from Jesse Landry

Company Spotlight
5th Line
Jul 17, 2026
Investor Spotlight
North Island Ventures
Jul 17, 2026
Events
America's Quantum Industrial Policy: Why Washington's Quantum Strategy Matters for Investors and Enterprise
Jul 17, 2026